Internal Medicine Alert – November 30, 2003

November 30, 2003

• Insurance Administrators, Take Note!

  Sleepiness, obesity, hypertension, witnessed apneas, and frequent snoring are prevalent in the general population; demand for diagnostic and treatment services for sleep apnea is likely to skyrocket.

  Read more

• The Longer You Stay, the Longer You Stay

  Like patients hospitalized with acute myocardial infarction and total knee replacements, EM of hospitalized patients with CAP reduces overall hospital length of stay and institutional resources without increasing the risk of adverse outcomes.

  Read more

• Duration of Antiviral Immunity After Smallpox Vaccination

  More than 90% of individuals studied maintain measurable humoral or T-cell-mediated immunity against vaccinia virus for as long as 75 years after smallpox vaccination.

  Read more

• Do You Know the Difference Between Impaired Fasting Glucose and Impaired Glucose Tolerance?

  The new criterion for FPG will identify many more individuals who are at risk for developing diabetes.

  Read more

• Pharmacology Update: Daptomycin Injection (Cubicin)

  The FDA has approved the first of a new class of antibiotics for the treatment of complicated skin and skin structure infections. Daptomycin is a cyclic lipopeptide that is active against Gram-positive bacteria.

  Read more

• Clinical Briefs

  St Johns Wort and Drug Interactions; Serum Potassium and Stroke Risk Among Hypertensive Adults; Skin Cancer Prevention and Detection Practices Among Siblings of Patients with Melanoma

  Read more